Trademarkia Logo

Canada

C$
DOLCIVE
REGISTERED

on 13 Nov 2019

Last Applicant/ Owned by

ABBVIE CORPORATION

8401 TransCanada HighwayMontreal

QUEBEC

CA

H4S1Z1

Serial Number

1847372 filed on 13th Jul 2017

Registration Number

TMA1062953 registered on 13th Nov 2019

Registration expiry Date

13th Nov 2029

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

DOLCIVE

Trademark usage description

pharmaceutical preparations used in connection with anti-aging, namely, for use in the treatment of glabellar lines, facial wrinkles, asymmetries and Read More

Classification Information


Class [005]
Pharmaceutical preparations used in connection with anti-aging, namely, for use in the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, and for facial aesthetic surgery, facial aesthetic reconstruction, and breast aesthetic treatment procedures; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma agents and decongestant formulations; sterile antibiotic ointments; ocular contact lens wetting solutions, artificial tears and pharmaceutical preparations for the treatment of minor ocular inflammations and allergic conditions; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lightener lotions and creams for the treatment of defects and conditions of the human skin; Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing pharmaceutical preparations; Pharmaceutical preparations and medicines for the treatment and prevention of sexual dysfunction; Pharmaceutical preparations and medicines for the treatment of sensory organ disorders; Pharmaceuticals and medicines for the treatment of the central nervous system, namely central nervous system infections, brain diseases, central nervous system disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, cerebral palsy, Parkinson's disease; Pharmaceutical preparations and medicines for the treatment of urogenital organ disorders; Pharmaceutical preparations and medicines for the treatment of circulatory system disorders; Pharmaceutical preparations and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders, namely Huntington's Disease, brain injury, seizure disorders, multiple sclerosis (MS) and amyotropic lateral sclerosis (ALS); Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceutical and cosmeceutical preparations for skin care, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body, used in connection with anti-aging, namely, for use in the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, and for use in connection with the treatment of eczema, psoriasis, dermatitis, skin pigmentation diseases, skin wounds, bacterial skin infections, fungal skin infections, viral skin infections, parasitic skin infections, skin irritations, namely bee stings, sunburn, rashes, sores, corns, calluses, and acne, for hydrating the skin during pregnancy, for preventing skin blemishes during pregnancy, and preparations for cleansing the skin for medical use


Classification kind code

11

Mark Details


Serial Number

1847372

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 190
on 16th Oct 2019
Registration Pending
Submitted for opposition 42
on 24th Jul 2019
Advertised
Submitted for opposition 26
on 8th Jul 2019
Approved
Submitted for opposition 27
on 8th Jul 2019
Approval Notice Sent
Submitted for opposition 12
on 16th Jan 2019
Extension of Time
Submitted for opposition 22
on 4th Jul 2018
Search Recorded
Submitted for opposition 20
on 4th Jul 2018
Examiner's First Report
Submitted for opposition 31
on 19th Jul 2017
Formalized
Submitted for opposition 1
on 14th Jul 2017
Created
Submitted for opposition 30
on 13th Jul 2017
Filed